OTC : CNPOF

RIV Capital Inc.

$0.08 USD

$0 (0.0%)

Volume
10.1K
Average Volume
74.9K
Market Capitalization
$10.96M
P/E Ratio
-0.15
Dividend Yield
0.00%
Price Target
Year High
$0.17
Year Low
$0.06
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$5.01
Company Overview

OTC

David E. Vautrin

Drug Manufacturers - Specialty & Generic

Healthcare

CNPOF

94

CA

USD

https://www.rivcapital.com

416-583-5945

N/A

N/A

Liquidity Metrics

2.94

5.01

4.48

4.18

0.00

Sales & Valuation

$5.65M

1.72

0.23

-0.51

-0.14

Profitability

-$0.48

-$65.01M

-1506.24%

-1425.74%

-112.58%

-38.86%

P/E Metrics

-0.15

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

0 Analysts

%

Financial Health Scores

-2.95

3/9

$59.85M

$198.99M

$170.11M

-$37.14M

Key Metrics (TTM)

$51.75M

9.18

-3.39

5.01

-112.58%

-34.21%

-881.07%

-197.10%

347 days

Company Executives
Name Title
Peter Hatziioannou Co-Founder & Advisor
David E. Vautrin Chief Retail Officer & Interim Chief Executive Officer
Matthew Jonathon Mundy Chief Strategy Officer, General Counsel & Corporate Secretary
Edward James Cirillo Lucarelli Chief Financial Officer
Sean McNulty Co-Founder & Advisor
Poll Results

No votes yet today — be the first to share your view!

About RIV Capital Inc. (OTC:CNPOF) Stock

RIV Capital Inc., previously known as Canopy Rivers Inc., functions as a venture capital firm. Although it employs a flexible investment strategy, engaging with companies from initial seed stages through to commercial sale, it primarily favors Series A to C funding rounds. The company's core focus is the expanding cannabis industry, specifically targeting promising marijuana enterprises. Its investment interests span numerous sub-sectors within the cannabis ecosystem, including agriculture and food sciences, production, processing, pharmaceuticals and biotechnology, software and data, hardware, consumer products and accessories, wellness products, retail and distribution, as well as media and content. The firm also allocates capital to specific product categories such as beverages, capsule ... s and concentrates, edibles, dry flower/pre-rolls, vaporizers and hardware, pet products, and topical applications. Within agriculture and food sciences, RIV Capital supports advancements in plant, soil, food, animal, and environmental sciences. Its production investments encompass various cultivation methods like indoor, greenhouse, outdoor, and nursery cultivation, along with fermentation. In processing, the firm backs activities including harvesting, extraction and purification, packaging, food and beverage processing, and laboratory testing services. For pharmaceuticals and biotechnology, areas of focus include drug discovery and development, diverse delivery methods (e.g., pills, soft gels, tinctures), biosynthetically derived cannabinoids and other molecules, medical devices (e.g., inhalers), and laboratory equipment. Consumer product interests extend to edibles, beverages, inhalables, cosmetics, and accessories for cannabis consumption. In retail and distribution, the firm targets licensed brick-and-mortar stores, pharmacies, online marketplaces, and delivery services. RIV Capital actively pursues investment opportunities on a global scale. While its historical investment amounts have varied from CA$1 million ($0.71 million) to CA$40 million ($28.45 million), typical investments generally fall within the range of CA$5 million ($3.6 million) to CA$10 million ($7.1 million). The firm predominantly seeks to acquire minority stakes and utilizes a variety of investment instruments, such as debt, preferred and common equity, and production-linked royalties. RIV Capital Inc. was established in 2017 and operates from its headquarters in Toronto, Canada.

Frequently Asked Questions

What is the current RIV Capital Inc. (CNPOF) stock price?

RIV Capital Inc.(OTC:CNPOF) stock price is $0.08 in the last trading session. During the trading session, CNPOF stock reached the peak price of $0.169 while $0.0621 was the lowest point it dropped to. The percentage change in CNPOF stock occurred in the recent session was 0.0% while the dollar amount for the price change in CNPOF stock was $0.

CNPOF's industry and sector of operation?

The OTC listed CNPOF is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CNPOF?

Peter Hatziioannou | Co-Founder & Advisor
David E. Vautrin | Chief Retail Officer & Interim Chief Executive Officer
Matthew Jonathon Mundy | Chief Strategy Officer, General Counsel & Corporate Secretary
Edward James Cirillo Lucarelli | Chief Financial Officer
Sean McNulty | Co-Founder & Advisor

How many employees does CNPOF have?

Number of CNPOF employees currently stands at 94. CNPOF operates from 40 King Street West, Toronto, ON M5H 3Y2, CA.

Link for CNPOF official website?

Official Website of CNPOF is: https://www.rivcapital.com

How do I contact CNPOF?

CNPOF could be contacted at phone #416-583-5945 and can also be accessed through its website. CNPOF operates from 40 King Street West, Toronto, ON M5H 3Y2, CA.

How many shares of CNPOF are traded daily?

The average number of CNPOF shares traded daily for last 3 months was 74.9K.

What is the market cap of CNPOF currently?

The market value of CNPOF currently stands at $10.96M with its latest stock price at $0.08